Glioblastoma Clinical Trials in Cincinnati, OH

Glioblastoma Clinical Trials in Cincinnati, OH

View the best 10 glioblastoma medical studies in Cincinnati, Ohio. Access promising new therapies by applying to a Cincinnati-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Cincinnati, Ohio

Here are the top 9 medical studies for glioblastoma in Cincinnati, Ohio

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Children's Hospital of Alabama in Birmingham, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

OKN-007 +1 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing a new drug, OKN-007, to see if it is effective, safe, and has the desired pharmacological properties when combined with the standard chemotherapy drug, temozolomide, in treating patients with recurrent glioblastoma.
Image of UC Irvine Health Cancer Center-Newport in Costa Mesa, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of James Graham Brown Cancer Center in Louisville, United States.

Temozolomide +1 More

Alkylating agent

Recruiting2 awardsPhase 1 & 2
This trial will study the effects of radiation and temozolomide on patients over 70 with cancer.
Image of Hartford Healthcare (Data Collection) in Hartford, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing if adding nivolumab to radiation therapy and bevacizumab improves treatment for recurrent glioblastoma.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.
Image of Littleton Adventist Hospital in Littleton, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

Popular filter options for glioblastoma cincinnati trials

Clinical Trials With No Placebo

View 40 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.